<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=217082&amp;fmt=gif">

MD Biosciences Blog

Breaking Science and Biotechnology News: Weekly Highlights

Posted by MD Biosciences on Nov 20, 2018 10:00:00 AM

MD Biosciences providing up-to-date news coverage compiling posts from science journals including News Medical, Journal of Knee SurgeryNature Communications, ScienceDaily and WVU News reporting fascinating and innovative discoveries happening all over the world across a wide variety of disciplinary areas. Skim the titles below to catch up on what is happening and to learn what the team at MD Biosciences is reading about. Follow the links to read more about something that catches your eye! 

Read More

Topics: Academic Research, Biomarkers, Biotechnology, Neuro/CNS, Immuno-Oncology, cancer/tumor, Neuroscience

Weekly Science News: Neuroscience and Biomarkers Making Leaps in Treating Human Disease

Posted by MD Biosciences on Nov 13, 2018 10:00:00 AM

MD Biosciences providing up-to-date news coverage compiling posts from science journals including EukerAlert, Gen News, Nature, Neuroscience News, Nature Communications, EMBO Molecular Medicine, ScienceDaily and Radiology reporting fascinating and innovative discoveries happening all over the world across a wide variety of disciplinary areas. Skim the titles below to catch up on what is happening and to learn what the team at MD Biosciences is reading about. Follow the links to read more about something that catches your eye! 

Read More

Topics: Academic Research, Biomarkers, Biotechnology, Neuro/CNS, Immuno-Oncology, cancer/tumor, Neuroscience

Genetics, Neuroscience and Immunotherapy: Weekly Science News

Posted by MD Biosciences on Nov 6, 2018 10:00:00 AM

MD Biosciences providing up-to-date news coverage compiling posts from science journals including British Journal of Cancer, Proceedings of the National Academy of Sciences, Neuroscience News, ScienceDaily, Science Translational Medicine and Stat News, reporting fascinating and innovative discoveries happening all over the world across a wide variety of disciplinary areas. Skim the titles below to catch up on what is happening and to learn what the team at MD Biosciences is reading about. Follow the links to read more about something that catches your eye! 

Read More

Topics: Academic Research, Biomarkers, Biotechnology, Neuro/CNS, Immuno-Oncology, cancer/tumor, Neuroscience

Changing the Future of Biomarkers and Human Disease Treatments: Biotechnology News

Posted by MD Biosciences on Nov 1, 2018 10:00:00 AM

MD Biosciences providing up-to-date news coverage compiling posts from science journals including Nature Cell Biology, Sci News, Journal of PLOS Biology, Medical Press, ScienceDaily and PhysOrg, reporting fascinating and innovative discoveries happening all over the world across a wide variety of disciplinary areas. Skim the titles below to catch up on what is happening and to learn what the team at MD Biosciences is reading about. Follow the links to read more about something that catches your eye! 

Read More

Topics: Academic Research, Biomarkers, Biotechnology, Neuro/CNS, Immuno-Oncology, cancer/tumor, Neuroscience

Immunotherapy, the Answer to Cancer?

Posted by MD Biosciences on Aug 30, 2016 2:46:55 PM

Immunoinhibitory checkpoints — act as the BREAKS of an immune system — shutting down the adaptive immune response. While inhibitory checkpoints such as PD-1 and CTLA-4 are important in the long-term prevention of auto-immune disorders, cancer will often take advantage of these signaling molecules to avoid destruction by the host immune system. In light of this, development of antagonistic monoclonal antibodies to block these signaling molecules has led to the FDA approval of both an anti-CTLA-4 monoclonal antibody, ipilimumab, and two anti-PD-1 antibodies, pembrolizumab and nivolumab, for the treatment of cancer.

These immunotherapeutic treatments have demonstrated versatility in the treatment of multiple cancer types. Nivolumab — first approved for the treatment of metastatic melanoma in late 2014 — has since been approved for treating advanced lung cancer and renal cell carcinoma, further illustrating the versatility of this immunotherapeutic approach. While demonstrating promise as single agents, the efficacious effects of these therapies are dramatically improved when they are used in combination with other chemo-radiation, or immuno-therapies. This exciting area of therapeutic potential is still in its infancy and continues to grow as more and more is learned about harnessing the body’s own capabilities to destroy cancer.

Read More

Topics: cancer/tumor, Immuno-Oncology